Adenios

About:

Adeniosc engages in the control of blood brain barrier permeability to improve treatment for multiple central nervous system diseases.

Website: http://www.adenios.com

Description:

Adenios technology both raises and lowers the permeability of the blood brain barrier to precisely control the delivery of existing drugs. The technology, spun out of Cornell University, can be paired with unmodified current therapeutics to either improve or block delivery of multiple compounds into the brain. The technology platform is currently in pre-clinical development aimed at controlling delivery of therapeutics for treatment of Alzheimer's, Parkinson's, brain cancer, multiple sclerosis, and other central nervous system diseases.

Total Funding Amount:

$810000

Headquarters Location:

Ithaca, New York, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)adenios.com

Founders:

Charlotte Hamilton, Margaret Bynoe

Number of Employees:

1-10

Last Funding Date:

2010-02-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai